2OOM | pdb_00002oom

NMR structure of a kissing complex formed between the TAR RNA element of HIV-1 and a LNA/RNA aptamer

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D NOESY	1 mM unlabeled TAR/aptamer complex; 10mM phosphate buffer pH 6.4	100% D2O		6.4	ambient	288
2	2D TOCSY	1 mM unlabeled TAR/aptamer complex; 10mM phosphate buffer pH 6.4	100% D2O		6.4	ambient	288
3	DQF-COSY	1 mM unlabeled TAR/aptamer complex; 10mM phosphate buffer pH 6.4	100% D2O		6.4	ambient	288
4	HMQC	1 mM 15N,13C TAR/unlabeled,aptamer complex; 10mM phosphate	100% D2O		6.4	ambient	288
5	3D HMQC-NOESY	1 mM 15N,13C TAR/unlabeled,aptamer complex; 10mM phosphate	100% D2O		6.4	ambient	288
6	3D HCCH-TOCSY	1 mM 15N,13C TAR/unlabeled,aptamer complex; 10mM phosphate	100% D2O		6.4	ambient	288
7	3D NOESY-NOESY	1 mM unlabeled TAR/aptamer complex; 10mM phosphate buffer pH 6.4	100% D2O		6.4	ambient	288
8	NOESY	1 mM unlabeled TAR/aptamer complex; 10mM phosphate buffer pH 6.4	90% H2O/10% D2O		6.4	ambient	288
9	HSQC	1 mM 15N,13C TAR/unlabeled,aptamer complex; 10mM phosphate buffer pH 6.4	90% H2O/10% D2O		6.4	ambient	288
10	2D NOESY	1 mM unlabeled TAR/aptamer complex; 10mM phosphate buffer pH 6.4	90% H2O/10% D2O		6.4	ambient	277

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE	500

NMR Ensemble Information
Conformer Selection Criteria	The submitted structures are the 12 structures with zero violation on NOE distance, dihedral and with the lowest energy.
Conformers Calculated Total Number	100
Conformers Submitted Total Number	12
Representative Model	1 (lowest energy)

Additional NMR Experimental Information
Details	The structure was determined using standard homonuclear and heteronuclear methods

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	refinement	CNS	1.1	Brunger A. T. etall

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.